Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: Indicator for concomitant high grade pancreatic intraepithelial neoplasia?

Familial Cancer

Volumn 12, Issue 1, 2013, Pages 89-96

  Bartsch, D K ^a   Dietzel, K ^a   Bargello, M ^a   Matthaei, E ^a   Kloeppel, G ^b   Esposito, I ^b   Heverhagen, J T ^a   Gress, T M ^a   Slater, E P ^a   Langer, P ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Familial pancreatic cancer; IPMN; PanIN; Screening

Indexed keywords

BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; ATROPHY; AUTOTRANSPLANTATION; CANCER SCREENING; CLINICAL ARTICLE; DISEASE MARKER; DISTRESS SYNDROME; FAMILIAL CANCER; FAMILIAL PANCREATIC CANCER; FEMALE; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; JAUNDICE; KLATSKIN TUMOR; LIVER FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PANCREAS; PANCREATIC NEOPLASMS;

EID: 84873405630     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-012-9582-y     Document Type: Article

References (32)

1. Bartsch DK (2003) Familial pancreatic cancer. Br J Surg 90:386-387
2. Bartsch DK, Sina-Frey M, Ziegler A, Hahn SA, Pryzpadlo E, Kress R, Gerdes B, Rieder H (2001) Update of familial pancreatic cancer in Germany. Pancreatology 1:510-516
3. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grützmann R, Rehder H, Rothmund M, Schmiegel W, Nepoptolemus JP, Bartsch DK (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95:214-221
4. Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, Hruban RA, Kern SE (2002) Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 117 %. Cancer Res 62:3789-3793
5. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217-220
6. Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoplotemos JP, Greenhalf W, Bartsch DK (2010) PALB2 mutations in European familial pancreatic cancer families. Clin Genet 78:490-494
7. Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu VE, Goggins M, Vogelstein B, Papadopoulos N, Hruban RH, Kinzler KW, Klein AP (2011) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2:41-46
8. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI (2007) Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56:1460-1469
9. Canto MI, Harink F, Hruban RH, Offerhaus J, Poley J-W, Fockens P, Kamel IR, Nio CY, Schulick RD, Basel C, Kluijt I, Goggins MG, Bruno MJ (2012) On behalf of the International CAPS Consortium. International consensus recommendations on the management of patients with increased risk for familial pancreatic cancer (Cancer of the Pancreas Screening Consortium (CAPS) 2011 Summit), to be presented at the Digestive Disease Week (DDW), San Diego, California, USA, May 19-May 22
10. Bartsch DK, Gress TM, Langer P (2012) Familial pancreatic cancer-current knowledge. Nat Rev Gastroenenterol Hepatol, ahead of print
11. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M (2012) American cancer of the pancreas screening (CAPS) consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804
12. Ohashi K, Murakami Y, Takekoshi T (1982) Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater. Progn Diagn Endosc 20:348-351
13. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplas and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17-32
14. Bussom S, Saif MW (2010) Intraductal papillary mucinous neoplasia (IPMN). JOP 11:131-134
15. Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, Ishida T, Takano Y, Tanaka S, Takenaka A (2008) Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57:1561-1565
16. Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M (2010) Predictors of the presence of concomitant invasive ductal carcinoma in intraductal. Ann Surg 251:70-75
17. Sipos B, Frank S, Gress T, Hahn SA, Klöppel G (2009) Pancreatic intraepithelial neoplaia revisited and updated. Pancreatology 9:45-54
18. Bartsch DK, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, Gerdes B, Rieder H (2001) Update of familial pancreatic cancer in Germany. Pancreatology 1:510-516
19. Langer P, Gress TM, Bartsch DK (2010) Pancreatic cancer screening in individuals at risk- too early for a general implementation on a health care basis. Gut 59:1006-1007
20. Fritz S, Klauss M, Bergmann F, Hackert T, Hartwig W, Strobel O, Bundy BD, Büchler MW, Werner J (2012) Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg 256:313-320
21. Aichler M, Seiler C, Tost M, Siveke J, Mazur PK, Da Silva-Buttkus P, Bartsch DK, Langer P, Chiblak S, Dürr A, Höfler H, Klöppel G, Müller-Decker K, Brielmeier M, Esposito I (2012) Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol 226:723-734
22. Schneider R, Slater EP, Sina M, Habbe N, Fendrich V, Matthäi E, Langer P, Bartsch DK (2011) German national case collection for familial pancreatic cancer (FaPaCa) ten years experience. Fam Cancer 10:323-330
23. Brune K, Abe T, Canto M, O'Malley L, Klein AP, Maitra A, Volkan Adsay N, Fishman EK, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Path 30:1067-1076
24. Nehra D, Ovaride VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo F (2012) Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology 12:358-363
25. Shi C, Goggins M, Maitra A, Canto M, Ali S, Schulick R, Palmisano E, Hruban RH (2009) Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 15(24):7737-7743
26. Salvia R, Crippa S, Partelli S, Armatura G, Malleo G, Paini M, Pea A, Bassi C (2010) Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2:342-346
27. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN (2006) Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4:766-781
28. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ (2009) The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 104:2175-2181
29. Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H (2010) Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 16:5028-5037
30. Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S (2011) Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg 30 [Epub ahead of print]
31. Vasen HF, Wasser M, van Mil A, Tollenaar RA, Konstantinovski M, Gruis NA, Bergman W, Hes FJ, Hommes DW, Offerhaus GJ, Morreau H, Bonsing BA, de Vos tot Nederveen Cappel WH (2011) Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 140:850-856
32. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114-1147